Incorporated in November 2023 and LegitScript-certified, FuturHealth runs a nationwide telehealth GLP-1 weight-loss program out of a San Diego corporate address on West Washington Street in the 92103. The model is membership-based rather than in-person, with compounded semaglutide and tirzepatide prescriptions shipped through partnered US pharmacies — a different track than the on-site injection and appetite-suppressant protocols run at MedArts Weight Loss Specialists elsewhere in the 92103. Members complete an intake questionnaire, attend a virtual provider consult, and receive medication shipments alongside in-app nutrition plans and dietitian messaging. For patients who want regenerative-medicine protocols or hormone balancing stacked alongside their weight-loss work, the in-clinic care delivered at Regenerative Wellness sits in a different therapeutic lane than FuturHealth's remote compounded-GLP-1 subscription. The most complex case type the platform handles is long-term GLP-1 maintenance with clinician-adjusted titration, side-effect management, and transition plans for patients moving between compounded semaglutide and branded Ozempic, Wegovy, or Zepbound prescriptions.